The bull case is essentially the same as ever: that Daxxify is the best botulinum toxin on the market and that RVNC will make a lot of money in due course. Compared to the original bull case, the only change is that it the initial sales ramp was hindered by RVNC’s overpricing the product, and hence it will take longer for the thesis to play out.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.